Share
- Release Date: 31/01/12 14:17
- Summary: RELINT: ABA: Ongoing Disclosure Notice - A. Clarke
- Price Sensitive: No
- Download Document 1.85KB
ABA
31/01/2012 12:17
RELINT
REL: 1217 HRS Abano Healthcare Group Limited
RELINT: ABA: Ongoing Disclosure Notice - A. Clarke
Ongoing Disclosure Notice
Disclosure of Directors and Officers Relevant Interests
Section 19T(2), Securities Markets Act 1988
A Details of director or officer
Name of director or officer of public issuer: Alan William CLARKE
Name of public issuer: Abano Healthcare Group Limited
Name of related body corporate (if applicable): N/A
Position held in public issuer: Managing Director
B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities:
(a) 5,900 ordinary shares
(b) 66 ordinary shares
C Nature of relevant interest and name of registered holder
Nature of relevant interest in those securities:
(a)Registered holder and beneficial owner
(b)Registered holder and discretionary beneficiary of the Clarke Family Trust
Name of registered holder of those securities
(a) Alan William CLARKE
(b) Alan William CLARKE, Margaret Clare ADAMS and Christopher David ROSS as
Trustees of The Clarke Family Trust
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: 27 January 2012
Consideration paid for acquisition: $4.04 per share
If the relevant interest was disposed of--
Date of disposal: N/a
Consideration received for disposal: N/a
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition or disposal took place: Issue of shares pursuant to
participation in the Dividend Reinvestment Plan for the 2012 interim dividend
E Total number of transactions this notice relates to: Two
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 5 December 2011
Date of signature: 31 January 2012
End CA:00219020 For:ABA Type:RELINT Time:2012-01-31 12:17:36
